SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
Posted on 07.01.2019 in Company Highlight, News

04.1.2019 – Sophia Genetics, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, a European leader in private equity, alongside existing investors including Balderton Capital and Alychlo.
Read the complete news on Sophia Genetics’ website